Skip to main content
Full access
Editorials
Published Online: 1 September 2019

In Search of a New Paradigm for Research on Violence and Schizophrenia

What do we know about the relationship between violence and schizophrenia? Violence is more common among people with schizophrenia than among people without mental disorders, roughly twice as frequent when controlling for the substantial effects of comorbid substance abuse (1). A large number of variables have been associated with this increased risk of violence, with the more robust including younger age, previous violence, antisocial traits, and medication nonadherence (2). Although risk prediction models appear to be able to identify subgroups of people with mental disorders who are at higher risk for violence, there is little evidence with regard to the accuracy of predictions for people with schizophrenia per se (3) and reasons to believe that there may be inherent limits on the precision of individual predictions (4).
Hence, notwithstanding the hundreds of studies of violence in schizophrenia and other psychoses over the past half century, psychiatrists faced with clinical, legal, and societal pressures to identify patients who are likely to engage in violent behavior remain in need of additional assistance to accomplish this task. It is precisely this need that motivates studies like the one by Buchanan et al. (5) in this issue of the Journal. Although the findings of this study contribute additional pieces to the puzzle of identifying patients at heightened risk for violence, the study also clearly illustrates many of the limitations of current research strategies.
Capitalizing on data from the multisite Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study on the comparative effectiveness of antipsychotic medications (6), the authors identified a small number of variables associated with an increased risk of violence that resulted in injury to another person. Baseline injurious violence, recent violent victimization, severity of drug use, baseline noninjurious violence, childhood sexual abuse, and medication nonadherence all heightened violence risk, although in the case of the last two variables, the increase was quite limited. Taken individually, there are no surprises here, since all of these have been found to be risk factors for future violence in previous studies. The authors suggest that the simultaneous large effect of having previously perpetrated and experienced violence represents a new contribution, but if so, it is surely a modest step forward.
However, the ways in which the Buchanan et al. study is typical of the literature on violence and mental illness exemplify many of the problems with current approaches. Conducting a secondary data analysis from a study not primarily designed to identify risk factors for violence, the authors were able only to assess those variables that were for other reasons included in the CATIE study. Thus, such presumptively relevant variables as lifetime arrest record and antisocial personality diagnosis appear not to have been available for this analysis. (Previous analyses from this data set showed that youthful antisocial behavior was a significant predictor of violence and comprised a subgroup with different antecedents of violence and responses to treatment [7, 8].) Moreover, the sample was arguably atypical of people with schizophrenia, consisting of patients who were not doing well on their medication at the time of enrollment, were willing to enter a longitudinal clinical trial, were switched to at least one new medication during the study period, and then were followed intensively by a research team over 18 months (9). The extent to which a sample such as this is useful in understanding violence among stable, community-dwelling patients with schizophrenia or persons newly discharged from an inpatient hospitalization is unclear.
Indeed, the opportunistic nature of most research on violence and schizophrenia (and other mental disorders) has inhibited progress in identifying the roots of violent behavior and potential preventive measures. Because they are typically reliant on data collected for other purposes, existing studies differ in sampling strategies (e.g., persons hospitalized for schizophrenia versus anyone with a schizophrenia diagnosis), diagnostic inclusion criteria (schizophrenia versus all psychoses), retrospective versus prospective design, independent variables, ascertainment of violence (arrest records versus self-report), and outcome measures (all interpersonal violence versus only injurious violence), among other methodological elements. Thus, systematic reviews and meta-analyses are handicapped by needing to combine data with very different characteristics in an effort to reach generalizable conclusions. Under these circumstances, it can hardly be surprising that—with the exception of variables of large effect such as previous violent history—studies routinely identify different predictors of violence, typically with small effects on overall risk.
Compounding this problem is the multifactorial nature of violence itself, with presumably causal factors, most with relatively small contributions to overall risk, having been identified at the individual, interpersonal, community, and societal levels (10). Individual-level factors include both demographic and biological variables, with violent behavior demonstrating moderate heritability (11). Violence differs in its goals (instrumental versus impulsive violence), its relationships between perpetrators and victims (intimate versus stranger violence), its nature (physical versus sexual violence), and its relationship to underlying mental disorders, if any. Indeed, even when perpetrated by people with serious mental disorders, only a small proportion of violence appears to be linked directly to symptoms of the disorders themselves (12). There is no inherent reason why the causal factors behind gang violence should be the same as those that precipitate assaults on an intimate partner, or why violence committed during a robbery should share predictors with an apparently unprovoked attack on a roommate, even when all are committed by a person with schizophrenia. By studying violent behavior as though it reflects a single phenomenon—with the Buchanan et al. study again being typical of the literature in this regard—research on violence and schizophrenia has been handicapped in identifying causal pathways.
How then can we move research on violence in schizophrenia forward? Without negating the contributions of the many researchers whose work has gotten us to where we are today, I would suggest that more secondary analyses of data collected for other purposes are unlikely to make substantial contributions to our understanding of violence by people with schizophrenia, the predictive accuracy of our models, or the development of preventive interventions. What is needed are prospective studies with violence as the primary outcome, sufficiently well powered to allow the identification and integration into multivariate models of the many variables that are likely to make some, usually modest, contribution to violence risk. Independent variables should be selected on the basis of their previous association with violence or strong theoretical reasons to believe that such an association can be demonstrated. Participants must be chosen with an eye to being able to generalize the results either to all people with schizophrenia or, likely more productively, to discrete subgroups that may be at increased violence risk, such as patients with first-episode psychosis (13). Outcome measures should be robust, preferably based on more than one method of ascertainment. Perhaps most useful of all would be the development of consensus methods for research on violence in schizophrenia and other mental disorders. Common sampling strategies, definitions of independent variables, and outcome measures would allow data to be aggregated across studies to increase the validity of systematic reviews and meta-analyses.
Notwithstanding that the importance of many of these approaches has been recognized for several decades (14), they continue to be honored largely in the breach by most research on violence and mental illness. However, another area of schizophrenia research demonstrates the value of pooling data in large consortia with agreement on analytic strategies. Research on the genetics of schizophrenia was stymied by many of the same problems affecting violence research, including a focus on a small number of predictive variables (“candidate genes”) that failed to replicate across studies (15). However, substantial advances have been made by an international consortium of researchers, the Psychiatric Genomics Consortium, that has pooled data from many different samples and used a technique, genome-wide association studies, that allows a vast number of genetic variants to be taken into account simultaneously (16). Although analogies across fields of research are always imperfect, the consortium approach is very much worth considering here.
As I have suggested elsewhere, however, there are likely to be irreducible limits to the ability to predict violence in schizophrenia or any other mental disorder due to “the unknowable contingencies of life. Will a person’s spouse leave or will the person lose his job or his home? As a consequence, will the person return to drinking, stop taking medication, or reconnect with friends who have continued to engage in criminal behaviors?” (17, p. 819). Thus, whatever the degree of violence risk a person is thought to present, particularly in the absence of demonstrated strategies for reducing that risk (18), the tasks of clinical care should focus on providing the best available evidence-based treatment and necessary psychosocial support.

References

1.
Fazel S, Gulati G, Linsell L, et al: Schizophrenia and violence: systematic review and meta-analysis. PLoS Med 2009; 6:e1000120
2.
Witt K, van Dorn R, Fazel S: Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies. PLoS One 2013; 8:e55942
3.
Singh JP, Serper M, Reinharth J, et al: Structured assessment of violence risk in schizophrenia and other psychiatric disorders: a systematic review of the validity, reliability, and item content of 10 available instruments. Schizophr Bull 2011; 37:899–912
4.
Monahan J, Skeem JL: The evolution of violence risk assessment. CNS Spectr 2014; 19:419–424
5.
Buchanan A, Sint K, Swanson J, et al: Correlates of future violence in people being treated for schizophrenia. Am J Psychiatry 2019; 176:694–701
6.
Lieberman JA, Stroup TS, McEvoy JP, et al: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209–1223
7.
Swanson JW, Van Dorn RA, Swartz MS, et al: Alternative pathways to violence in persons with schizophrenia: the role of childhood antisocial behavior problems. Law Hum Behav 2008; 32:228–240
8.
Swanson JW, Swartz MS, Van Dorn RA, et al: Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. Br J Psychiatry 2008; 193:37–43
9.
Stroup TS, McEvoy JP, Swartz MS, et al: The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 2003; 29:15–31
10.
Krug EG, Dahlberg LL, Mercy JA, et al: World Report on Violence and Health. Geneva, World Health Organization, 2002
11.
Frisell T, Pawitan Y, Långström N, et al: Heritability, assortative mating and gender differences in violent crime: results from a total population sample using twin, adoption, and sibling models. Behav Genet 2012; 42:3–18
12.
Peterson JK, Skeem J, Kennealy P, et al: How often and how consistently do symptoms directly precede criminal behavior among offenders with mental illness? Law Hum Behav 2014; 38:439–449
13.
Nielssen O, Large M: Rates of homicide during the first episode of psychosis and after treatment: a systematic review and meta-analysis. Schizophr Bull 2010; 36:702–712
14.
Monahan J, Steadman HJ: Toward a rejuvenation of risk assessment research, in Violence and Mental Disorder: Developments in Risk Assessment. Edited by Monahan J, Steadman HJ. Chicago, University of Chicago Press, 1994
15.
Johnson EC, Border R, Melroy-Greif WE, et al: No evidence that schizophrenia candidate genes are more associated with schizophrenia than noncandidate genes. Biol Psychiatry 2017; 82:702–708
16.
Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511:421–427
17.
Appelbaum P: Reference guide on mental health evidence, in Federal Judicial Center: Reference Manual on Scientific Evidence. Washington, DC, National Academies Press, 2011, pp 813–896
18.
Large M, Nielssen O: The limitations and future of violence risk assessment. World Psychiatry 2017; 16:25–26

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 677 - 679
PubMed: 31474122

History

Accepted: 2 July 2019
Published online: 1 September 2019
Published in print: September 01, 2019

Keywords

  1. Violence/Aggression
  2. Schizophrenia

Authors

Details

Paul S. Appelbaum, M.D. [email protected]
The Center for Law, Ethics, and Psychiatry, Department of Psychiatry, Columbia University, New York.

Notes

Send correspondence to Dr. Appelbaum ([email protected]).

Funding Information

Dr. Appelbaum is the Elizabeth K. Dollard Professor of Psychiatry, Medicine and Law, and Director, Center for Law, Ethics, and Psychiatry, Department of Psychiatry, Columbia University.The author reports no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share